A retrospective study on unfavorable 28-day neurological outcomes of stage II TB meningitis

一项关于 II 期结核性脑膜炎 28 天不良神经系统结局的回顾性研究

阅读:1

Abstract

Tuberculous meningitis (TBM) is often associated with adverse neurological outcomes, however, there is a lack of relevant research. The aim of this study is to explore the risk factors that affect the poor prognosis of 28-day neurological function in patients with stage II TBM. A retrospective analysis was conducted on the clinical data of patients with stage II TBM who visited our hospital from January 1st, 2018 to August 1st, 2019 based on the staging criteria of the Medical Research Council. The neurological function prognosis after 28 days of follow-up was determined to establish independent risk factors. A total of 138 patients (82 male and 56 female) were included, with an average onset age of 37.01 ± 17.30 years. Forty patients had poor prognosis (Modified Rankin Scale [MRS] score, 3-6 points), while 98 patients had a good prognosis (MRS score, 0-2 points). Multivariate logistic regression analysis showed that peripheral nerve dysfunction (odds ratio [OR], 6.315; 95% confidence interval [CI] 2.319-17.196; p < 0.001), Quick Sequential Organ Failure Assessment (QSOFA) score (OR 7.343; 95% CI 2.984-18.066; p < 0.001), and hydrocephalus (OR 2.685; 95% CI 1.020-7.068; p = 0.045) were independent risk factors. The area under the curve for predicting the 28-day neurological prognosis of patients with stage II TBM using the QSOFA score was 0.766 (95% CI 0.680-0.853; p < 0.001). Peripheral nerve dysfunction, QSOFA score, and hydrocephalus are independent risk factors for 28-day neurological dysfunction in patients with stage II TBM. The QSOFA score had good predictive ability of the prognosis in terms of 28-day neurological function of patients with stage II TBM.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。